Latest Breaking News On - Robertb stein - Page 1 : vimarsana.com

Protagenic Therapeutics Stress-Regulating Peptide Demonstrates Exceptional

Protagenic Therapeutics Stress-Regulating Peptide Demonstrates Exceptional
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesRobertb steinProtagenic therapeutics incNews networkAdvisory incCompany contactClinically relevant adverse events reportedSingle dose portionMultiple dose portionCall scheduledDiscuss potential impactProtagenic therapeuticsChief medicalAccess codeLooking statements

Protagenic Therapeutics, Inc : Protagenic Therapeutics Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychi

No Clinically-Relevant Adverse Events Reported in Single Dose Portion, Multiple Dose Portion to CommenceInvestor Call Scheduled for today, Wednesday, May 22, at 10:00 am ET to Discuss Potential Impact

New yorkUnited statesRobertb steinCompany contactAdvisory incProtagenic therapeutics incSingle dose portionMultiple dose portionCall scheduledDiscuss potential impactProtagenic therapeuticsChief medicalAccess codeLooking statementsChief financial officerRelations contact

Protagenic Therapeutics (PTIX) Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial

Protagenic Therapeutics (PTIX) Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Robertb steinProtagenic therapeutics incSingle dose portionMultiple dose portionCall scheduledDiscuss potential impactChief medical

Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

Call Scheduled for Monday, April 1st, 2024, at 4:30 pm ETNEW YORK, NY / ACCESSWIRE / March 25, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a biopharmaceutical innovator, announced that the Company plans to hold its first investor earnings call to discuss the results contained in its FY 2023 Form 10K, which i.

New yorkUnited statesAndrew sleeGaroh armenRobertb steinCompany contactProtagenic therapeutics incAdvisory incCall scheduledProtagenic therapeuticsChief medical officerChief operating officerToll freeAccess codeCorticotropin releasing factorLooking statements

Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

New yorkUnited statesRobertb steinGaroh armenAndrew sleeAdvisory incNews networkProtagenic therapeutics incCompany contactProtagenic therapeuticsChief medical officerChief operating officerToll freeAccess codeCorticotropin releasing factorLooking statements